Literature DB >> 11060189

Long-term follow-up after treatment of Mirizzi syndrome by peroral cholangioscopy.

T Tsuyuguchi1, H Saisho, T Ishihara, T Yamaguchi, E K Onuma.   

Abstract

BACKGROUND: The standard treatment for Mirizzi syndrome is surgical, although endoscopic and percutaneous management have also been described. The aim of this study was to evaluate the usefulness of shock wave lithotripsy combined with peroral cholangioscopy and its long-term outcome in patients with Mirizzi syndrome.
METHODS: The records of 25 patients with Mirizzi syndrome who underwent endoscopic treatment between April 1990 and November 1998 were retrospectively reviewed. Shock wave lithotripsy was performed under direct vision with a "mother-baby" endoscope system in 2 patients with type I and 23 with type II Mirizzi syndrome (12 men and 13 women, mean age 60 years). Follow-up data were obtained from clinical records or through telephone interviews.
RESULTS: In the two patients with type I, the cholangioscopic approach failed and both patients underwent open cholecystectomy. The 23 patients with type II were all successfully treated with shock wave lithotripsy alone. The cholangioscopic approach was unsuccessful in the treatment of residual gallbladder stones. Follow-up data were obtained in all but one patient (mean 43.6 months, range 4 to 103 months). Of the 23 patients with type II, 12 with no gallbladder stones had remained asymptomatic during the follow-up period. Of the 6 patients with type II with large residual gallbladder stones, 4 had acute cholangitis due to stone migration 6, 9, 28, and 34 months after endoscopic treatment. Two patients died during the follow-up period, one of non-biliary causes and the other of coexistent gallbladder carcinoma.
CONCLUSIONS: Endoscopic treatment of Mirizzi syndrome using peroral cholangioscopy is a safe and effective alternative to surgery, especially in patients with the type II syndrome. A favorable long-term outcome depends on the absence of large residual gallbladder stones.

Entities:  

Mesh:

Year:  2000        PMID: 11060189     DOI: 10.1067/mge.2000.108971

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  14 in total

1.  Long-term follow-up after peroral cholangioscopy-directed lithotripsy in patients with difficult bile duct stones, including Mirizzi syndrome: an analysis of risk factors predicting stone recurrence.

Authors:  Toshio Tsuyuguchi; Yuji Sakai; Harutoshi Sugiyama; Takeshi Ishihara; Osamu Yokosuka
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

2.  Mirizzi syndrome.

Authors:  Sushil K Ahlawat; Rohit Singhania; Firas H Al-Kawas
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

Review 3.  Intraductal biliary and pancreatic endoscopy: an expanding scope of possibility.

Authors:  Joel R Judah; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

4.  A Case of Type IV Cholecystobiliary Fistula.

Authors:  Sushil K Ahlawat; Rohit Singhania
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-12

5.  Mirizzi syndrome.

Authors:  Md Ibrarullah; Tapas Mishra; A P Das
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

Review 6.  Mirizzi syndrome: laparoscopic management by subtotal cholecystectomy.

Authors:  A Rohatgi; K K Singh
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

7.  The Mirizzi syndrome: multidisciplinary management promotes optimal outcomes.

Authors:  Rozina Mithani; Wayne H Schwesinger; Juliane Bingener; Kenneth R Sirinek; Glenn W W Gross
Journal:  J Gastrointest Surg       Date:  2007-09-14       Impact factor: 3.452

8.  Difficult bile duct stones.

Authors:  Lee McHenry; Glen Lehman
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

9.  Mirizzi syndrome with endoscopic ultrasound image.

Authors:  K Rayapudi; P Gholami; M Olyaee
Journal:  Case Rep Gastroenterol       Date:  2013-05-04

10.  Mirizzi Syndrome.

Authors:  Guillermo Gomez
Journal:  Curr Treat Options Gastroenterol       Date:  2002-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.